03:12 AM EST, 12/05/2024 (MT Newswires) -- Laura Shawver, Director, on December 02, 2024, sold 200,000 shares in ARS Pharmaceuticals ( SPRY ) for $2,688,751. Following the Form 4 filing with the SEC, Shawver has control over a total of 210,346 shares of the company, with 210,346 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/xslF345X05/form4-12042024_091203.xml